risperidone has been researched along with memantine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 12 (57.14) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brüne, M; Schröder, SG | 1 |
| Kato, S; Nisijima, K; Shioda, K; Takano, K; Yoshino, T | 1 |
| Arya, P; Butler, R; Warner, J | 1 |
| Sleeper, RB | 1 |
| Cakir, A; Cankurtaran, ES; Ozalp, E; Soygur, H | 1 |
| Arai, Y; Nakagawasai, O; Nakaya, K; Niijima, F; Onogi, H; Sato, A; Tadano, T; Tan-No, K | 1 |
| Akhondzadeh, S; Asadabadi, M; Ghaleiha, A; Hajiaghaee, R; Hassanzadeh, E; Mohammadi, MR; Shahei, M; Tabrizi, M | 1 |
| Akhondzadeh, S; Ashrafi, M; Hajiaghaee, R; Hammidi, S; Modabbernia, A; Mohammad-Karimi, M; Motasami, H; Rezaei, F; Salehi, B; Seddighi, S; Tabrizi, M | 1 |
| Brown, GD; Muzyk, AJ; Preud'homme, XA | 1 |
| Alaghband-Rad, J; Alimadadi, A; Ghaeli, P; Nikvarz, N; Tehrani-Doost, M | 1 |
| Khodaei, M; Mazinani, R; Nejati, S | 1 |
| Iwata, N; Kishi, T; Matsuda, Y | 1 |
| Buckley, N; Le Couteur, DG; Litchfield, M; McLachlan, AJ; Narayan, SW; Pearson, SA; Zoega, H | 1 |
| Gallinat, J; Heinz, A; Leopold, K; Sarkar, S; Schaefer, M; Theophil, I | 1 |
| Chen, KL; Chen, SD; Dong, Q; Dou, KX; Huang, YY; Shen, XN; Tan, L; Teng, T; Wang, J; Wang, RZ; Yu, JT; Zhang, RQ; Zhao, QH; Zhong, XL; Zhou, XY | 1 |
| Abdelgalil, MS; Ali, MM; Benmelouka, AY; Brimo Alsaman, MZ; Elgendy, AMN; Elnaiem, W; Mogheeth, A; Yousof, SM | 1 |
4 review(s) available for risperidone and memantine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E | 2004 |
Pharmacological treatments for psychotic symptoms in dementia: A systematic review with pairwise and network meta-analysis.
Topics: Aripiprazole; Dementia; Donepezil; Humans; Memantine; Network Meta-Analysis; Risperidone; United States | 2022 |
Evaluation of memantine's efficacy and safety in the treatment of children with autism spectrum disorder: A systematic review and meta-analysis.
Topics: Anxiety Disorders; Autism Spectrum Disorder; Child; Excitatory Amino Acid Antagonists; Humans; Memantine; Risperidone | 2022 |
4 trial(s) available for risperidone and memantine
| Article | Year |
|---|---|
Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
Topics: Autistic Disorder; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Memantine; Risperidone; Treatment Outcome | 2013 |
Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study.
Topics: Adult; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Humans; Male; Memantine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome | 2013 |
Effects of memantine added to risperidone on the symptoms of schizophrenia: A randomized double-blind, placebo-controlled clinical trial.
Topics: Adult; Antipsychotic Agents; Cognition; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Memantine; Middle Aged; Neuropsychological Tests; Psychopathology; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2017 |
Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Attention; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Memantine; Memory; Problem Solving; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Socioeconomic Factors; Verbal Learning; Young Adult | 2020 |
13 other study(ies) available for risperidone and memantine
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Erotomania variants in dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Bipolar Disorder; Delusions; Dementia, Vascular; Dopamine Agents; Drug Administration Schedule; Female; Humans; Male; Memantine; Neuropsychological Tests; Risperidone; Severity of Illness Index; Sexual Behavior | 2003 |
Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome.
Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Clorgyline; Disease Models, Animal; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Fever; Hypothalamus; Ketamine; Male; Memantine; Microdialysis; Norepinephrine; Rats; Rats, Wistar; Risperidone; Serotonin; Serotonin Antagonists; Serotonin Syndrome; Time Factors | 2004 |
Antipsychotic dose-sparing effect with addition of memantine.
Topics: Aged; Aggression; Alzheimer Disease; Antipsychotic Agents; Dopamine Agents; Drug Therapy, Combination; Humans; Male; Memantine; Risperidone | 2005 |
Clinical experience with risperidone and memantine in the treatment of Huntington's disease.
Topics: Adult; Cognition; Dopamine Antagonists; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Follow-Up Studies; Humans; Huntington Disease; Memantine; Risperidone | 2006 |
Pharmacological characterizations of memantine-induced disruption of prepulse inhibition of the acoustic startle response in mice: involvement of dopamine D2 and 5-HT2A receptors.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Benzazepines; Clozapine; Dopamine Agents; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Haloperidol; Ketanserin; Male; Memantine; Mice; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Reflex, Startle; Risperidone; Sensory Gating | 2011 |
Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine.
Topics: Catatonia; Delirium; Excitatory Amino Acid Antagonists; Humans; Liver Transplantation; Male; Memantine; Middle Aged; Non-alcoholic Fatty Liver Disease; Patient Readmission; Postoperative Complications; Risperidone; Serotonin Antagonists | 2016 |
Comparing Efficacy and Side Effects of Memantine vs. Risperidone in the Treatment of Autistic Disorder.
Topics: Autistic Disorder; Child; Child, Preschool; Dopamine Agents; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Male; Memantine; Psychiatric Status Rating Scales; Risperidone; Time Factors; Treatment Outcome | 2017 |
Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis.
Topics: Adult; Antipsychotic Agents; Cognition; Double-Blind Method; Humans; Memantine; Risperidone; Schizophrenia | 2017 |
Anticholinergic medicines use among older adults before and after initiating dementia medicines.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Australia; Cholinergic Antagonists; Cholinesterase Inhibitors; Dementia; Deprescriptions; Donepezil; Drug Prescriptions; Female; Humans; Male; Memantine; Middle Aged; Retrospective Studies; Risperidone; Rivastigmine | 2019 |